Nephros Therapeutics Becomes RenaMed Biologics
10/19/2005 5:12:55 PM
LINCOLN, R.I.--(BUSINESS WIRE)--Sept. 27, 2005--Nephros Therapeutics has changed its name to RenaMed Biologics(TM) (RenaMed(TM)). The name change reflects the company's mission to extend and improve the lives of patients with critical diseases involving severely compromised kidney function. RenaMed is a leading clinical stage company focused on the development of Bio-Replacement Therapies(TM) for Acute Renal Failure and other life-threatening diseases.